HC Wainwright Issues Negative Outlook for CVE:HIV Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIVFree Report) – Investment analysts at HC Wainwright dropped their FY2026 earnings estimates for shares of HIVE Blockchain Technologies in a report released on Tuesday, February 17th. HC Wainwright analyst M. Colonnese now anticipates that the company will earn ($0.74) per share for the year, down from their prior forecast of ($0.40). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at ($0.27) EPS, Q1 2027 earnings at ($0.21) EPS, Q2 2027 earnings at ($0.12) EPS, Q3 2027 earnings at ($0.04) EPS, Q4 2027 earnings at $0.00 EPS and FY2027 earnings at ($0.37) EPS.

A number of other research analysts have also weighed in on the company. B. Riley Financial raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, November 21st. Keefe, Bruyette & Woods lowered HIVE Blockchain Technologies from a “moderate buy” rating to a “hold” rating in a report on Tuesday, January 27th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy”.

Check Out Our Latest Research Report on HIVE Blockchain Technologies

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.

Featured Stories

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.